Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank62
3Y CAGR-66.4%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-66.4%/yr
Quarterly compound
Percentile
P62
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 1.05% |
| Q3 2025 | -14.19% |
| Q2 2025 | 42.22% |
| Q1 2025 | -114.12% |
| Q4 2024 | 25.26% |
| Q3 2024 | 13.28% |
| Q2 2024 | 63.99% |
| Q1 2024 | -174.80% |
| Q4 2023 | -0.44% |
| Q3 2023 | 30.29% |
| Q2 2023 | -15.04% |
| Q1 2023 | -7.30% |
| Q4 2022 | 27.79% |
| Q3 2022 | -9.83% |
| Q2 2022 | 20.26% |
| Q1 2022 | -32.61% |
| Q4 2021 | -0.68% |
| Q3 2021 | -8.57% |
| Q2 2021 | -10.57% |
| Q1 2021 | -14.85% |
| Q4 2020 | -7.54% |
| Q3 2020 | 8.64% |
| Q2 2020 | 17.64% |
| Q1 2020 | -12.03% |
| Q4 2019 | 4.85% |
| Q3 2019 | -21.55% |
| Q2 2019 | 13.45% |
| Q1 2019 | -50.57% |
| Q4 2018 | -23.87% |
| Q3 2018 | -38.18% |
| Q2 2018 | -7.20% |
| Q1 2018 | -46.74% |
| Q4 2017 | 6.53% |
| Q3 2017 | -38.31% |
| Q2 2017 | 12.46% |
| Q1 2017 | -13.55% |
| Q4 2016 | -36.89% |
| Q3 2016 | 31.97% |
| Q2 2016 | 4.50% |
| Q1 2016 | -88.91% |